Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexamethasone for prevention of postoperative nausea and vomiting after hysterectomy
IRCT20180416039326N13Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Incidence of nausea, Score of nausea and 14 more. Started Jun 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180416039326N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N13.